The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies
Open accessAbstract
Background— Measurement of B-type natriuretic peptide (BNP) concentration or its precursor (N-terminal fragment [NT-proBNP]) is recommended in patients with symptoms of left ventricular dysfunction and in other settings, but the relevance of these peptides to cardiovascular disease (CVD) in general populations or in patients with stable vascular disease is uncertain. Methods and Results— Data were collated from 40 long-term prospective studies involving a total of 87 474 participants and 10 625 incident CVD outcomes. In a comparison of individuals in the top third with those in the bottom third of baseline values of natriuretic peptides, the combined risk ratio (RR), adjusted for several conventional risk factors, was 2.82 (95% confidence interval [CI], 2.40 to 3.33) for CVD. Analysis of the 6 studies with at least 250 CVD outcomes (which should be less prone to selective reporting than are smaller studies) yielded an adjusted RR of 1.94 (95% CI, 1.57 to 2.39). RRs were broadly similar with BNP or NT-proBNP (RR, 2.89 [95% CI, 1.91 to 4.38] and 2.82 [95% CI, 2.35 to 3.38], respectively) and by different baseline vascular risk (RR, 2.68 [95% CI, 2.07 to 3.47] in approximately general populations; RR, 3.35 [95% CI, 2.38 to 4.72] in people with elevated vascular risk factors; RR, 2.60 [95% CI, 1.99 to 3.38] in patients with stable CVD). Assay of BNP or NT-proBNP in addition to measurement of conventional CVD risk factors yielded generally modest improvements in risk discrimination. Conclusions— Available prospective studies indicate strong associations between circulating concentration of natriuretic peptides and CVD risk under a range of different circumstances. Further investigation is warranted, particularly in large general population studies, to clarify any predictive utility of these markers and to better control for publication bias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Self-citationAuthors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Self-citationEpstein, F. H., Levin, E. R., Gardner, D. G., & Samson, W. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390507 · Cited by 1,927
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Daniels, L. B., & Maisel, A. S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.021 · Cited by 952
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
State of the art: using natriuretic peptide levels in clinical practice
Maisel, A., Mueller, C., Adams, K., Anker, S. D., Aspromonte, N., Cleland, J. G. F., Cohen-Solal, A., Dahlstrom, U., DeMaria, A., Di Somma, S., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.07.014 · Cited by 839
Doust, J. A., Pietrzak, E., Dobson, A., & Glasziou, P. (2005) · BMJ · doi:10.1136/bmj.330.7492.625 · Cited by 710
N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease
Kragelund, C., Grønning, B., Køber, L., Hildebrandt, P., & Steffensen, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042330 · Cited by 631
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., & Christenson, R. H. (2007) · Circulation · doi:10.1161/circulationaha.107.182882 · Cited by 610
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander, O. (2009) · JAMA · doi:10.1001/jama.2009.943 · Cited by 551
Hama, N., Itoh, H., Shirakami, G., Nakagawa, O., Suga, S.-I., Ogawa, Y., Masuda, I., Nakanishi, K., Yoshimasa, T., Hashimoto, Y., et al. (1995) · Circulation · doi:10.1161/01.cir.92.6.1558 · Cited by 426
Increased cardiac BNP expression associated with myocardial ischemia
Goetze, J. P., Christoffersen, C., Perko, M., Arendrup, H., Rehfeld, J. F., Rastrup, J., & Nielsen, L. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-0796fje · Cited by 353
Bibbins-Domingo, K., Gupta, R., Na, B., Wu, A. H. B., Schiller, N. B., & Whooley, M. A. (2007) · JAMA · doi:10.1001/jama.297.2.169 · Cited by 276
Blankenberg, S., McQueen, M. J., Smieja, M., Pogue, J., Balion, C., Lonn, E., Rupprecht, H. J., Bickel, C., Tiret, L., Cambien, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.590927 · Cited by 256
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease
Omland, T., Sabatine, M. S., Jablonski, K. A., Rice, M. M., Hsia, J., Wergeland, R., Landaas, S., Rouleau, J. L., Domanski, M. J., Hall, C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.038 · Cited by 229
Daniels, L. B., Laughlin, G. A., Clopton, P., Maisel, A. S., & Barrett-Connor, E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.033 · Cited by 197
Groenning, B. A., Raymond, I., Hildebrandt, P. R., Nilsson, J. C., Baumann, M., & Pedersen, F. (2004) · Heart · doi:10.1136/hrt.2003.026021 · Cited by 188
Tateishi, J., Masutani, M., Ohyanagi, M., & Iwasaki, T. (2000) · Clinical Cardiology · doi:10.1002/clc.4960231016 · Cited by 170
Olsen, M. H., Hansen, T. W., Christensen, M. K., Gustafsson, F., Rasmussen, S., Wachtell, K., Ibsen, H., Torp-Pedersen, C. T., & Hildebrandt, P. R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl448 · Cited by 136
Lindahl, B., Lindbäck, J., Jernberg, T., Johnston, N., Stridsberg, M., Venge, P., & Wallentin, L. C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.057 · Cited by 126
Sadanandan, S., Cannon, C. P., Chekuri, K., Murphy, S. A., DiBattiste, P. M., Morrow, D. A., de Lemos, J. A., D, E. B. M., & Gibson, C. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.072 · Cited by 118
Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes
Tarnow, L., Gall, M.-A., Hansen, B. V., Hovind, P. H., & Parving, H. ‐. (2006) · Diabetologia · doi:10.1007/s00125-006-0359-4 · Cited by 111
Heart Protection Study Collaborative Group (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.052 · Cited by 110
G�de, P., Hildebrandt, P., Hess, G., Parving, H.-H., & Pedersen, O. (2005) · Diabetologia · doi:10.1007/s00125-004-1607-0 · Cited by 105
Wood, A., White, I. R., Thompson, S. G., Lewington, S., & Danesh, J. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl233 · Cited by 104
Self-citationHuelsmann, M., Neuhold, S., Strunk, G., Moertl, D., Berger, R., Prager, R., Abrahamian, H., Riedl, M., Pacher, R., Luger, A., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn334 · Cited by 92
Campbell, D. J., Woodward, M., Chalmers, J. P., Colman, S. A., Jenkins, A. J., Kemp, B. E., Neal, B. C., Patel, A. A., & MacMahon, S. W. (2005) · Circulation · doi:10.1161/circulationaha.104.525527 · Cited by 80
Scirica, B. M., Cannon, C. P., Sabatine, M. S., Jarolím, P., Sloane, S., Rifai, N., Braunwald, E., Morrow, D. A., & for the PROVE IT–TIMI 22 Investigators (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.117192 · Cited by 70
Rothenbacher, D., Köenig, W., & Brenner, H. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2455 · Cited by 55
Astor, B. C., Yi, S. S., Hiremath, L., Corbin, T., Pogue, V. A., Wilkening, B., Peterson, G., Lewis, J., Lash, J. P., Lente, F. V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.724187 · Cited by 51
März, W., Tiran, B., Seelhorst, U., Wellnitz, B., Bauersachs, J. K., Winkelmann, B. R., & Boehm, B. O. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.075929 · Cited by 49
Brain Natriuretic Peptide as a Risk Marker for Incident Hypertensive Cardiovascular Events.
Suzuki, M., Hamada, M., Yamamoto, K., Kazatani, Y., & Hiwada, K. (2002) · Hypertension Research · doi:10.1291/hypres.25.669 · Cited by 48
Laukkanen, J. A., Kurl, S., Ala‐Kopsala, M., Vuolteenaho, O. J., Ruskoaho, H. J., Nyyssönen, K., & Salonen, J. T. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi878 · Cited by 48
Risk of cardiovascular death in elderly patients with possible heart failure
Alehagen, U., Lindstedt, G., Levin, L., & Dahlström, U. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.006 · Cited by 47
West, M., Nestel, P. J., Kirby, A. C., Schnabel, R. B., SULLIVAN, D. R., Simes, R. J., Pollicino, C., Lubos, E., Münzel, T. F., White, H. D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn007 · Cited by 42
Takahashi, T., Nakamura, M., Onoda, T., Ohsawa, M., Tanno, K., Itai, K., Sakata, K., Sakuma, M., Tanaka, F., Makita, S., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.029 · Cited by 41
A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease
Oremus, M., Raina, P. S., Santaguida, P. L., Balion, C. M., McQueen, M., McKelvie, R. S., Worster, A., Booker, L., & Hill, S. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.09.011 · Cited by 40
Olsen, M. H., Wachtell, K., Nielsen, O. W., Hall, C., Wergeland, R., Ibsen, H., Kjeldsen, S. E., Devereux, R. B., Dahlöf, B., & Hildebrandt, P. R. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000239288.10013.04 · Cited by 38
Mueller, T., Dieplinger, B., Poelz, W., Endler, G., Wagner, O. F., & Haltmayer, M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108753 · Cited by 35
Prognostic threshold levels of NT-proBNP testing in primary care
Rosenberg, J., Schou, M., Gustafsson, F., Badskjaer, J., & Hildebrandt, P. R. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn525 · Cited by 30
SUTTER, J. D., Bacquer, D. D., Cuypers, S., Delanghe, J., Buyzere, M. D., Kornitzer, M., & Backer, G. D. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi502 · Cited by 27
Kubozono, T., Itoh, H., Oikawa, K., Tajima, A., Maeda, T., Aizawa, T., Iinuma, H., Tokuda, Y., Ohashi, Y., & Fu, L.-T. (2007) · Circulation Journal · doi:10.1253/circj.72.575 · Cited by 24
Shadman, R., Allison, M., & Criqui, M. H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.047 · Cited by 22
Coronary angiography transiently increases plasma pro-B-type natriuretic peptide
Goetze, J. P. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.02.009 · Cited by 17
NT-pro-BNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatients
Pfister, R., Tan, D., Thekkanal, J., Hellmich, M., & Schneider, C. A. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.11.007 · Cited by 15
Huang, P., Lu, T., Wu, T.-C., Lin, F., Chen, Y., Chen, J., & Lin, S. (2008) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282f399e2 · Cited by 11
Cited by
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324
C-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
Braunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
deFilippi, C. R., de Lemos, J. A., Christenson, R. H., Gottdiener, J. S., Kop, W. J., Zhan, M., & Seliger, S. L. (2010) · JAMA · doi:10.1001/jama.2010.1708 · Cited by 715
Metadata
- Authors
- Di Angelantonio, E., Chowdhury, R., Sarwar, N., Ray, K. K., Gobin, R., Saleheen, D., Thompson, A., Gudnason, V., Sattar, N., & Danesh, J.
- Venue
- Circulation
- Published
- 2009-12
- Volume
- 120
- Issue
- 22
- Pages
- 2177-2187
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2164602128
- Cited by
- 378
- References
- 54
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.